These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
253 related items for PubMed ID: 18582459
1. PON1Q192R polymorphism is associated with lipid profile in Mexican men with Mayan ascendancy. Pérez-Herrera N, May-Pech C, Hernández-Ochoa I, Castro-Mañé J, Rojas-García E, Borja-Aburto VH, Castillo-Burguete T, Quintanilla-Vega B. Exp Mol Pathol; 2008 Oct; 85(2):129-34. PubMed ID: 18582459 [Abstract] [Full Text] [Related]
2. PON1Q192R genetic polymorphism modifies organophosphorous pesticide effects on semen quality and DNA integrity in agricultural workers from southern Mexico. Pérez-Herrera N, Polanco-Minaya H, Salazar-Arredondo E, Solís-Heredia MJ, Hernández-Ochoa I, Rojas-García E, Alvarado-Mejía J, Borja-Aburto VH, Quintanilla-Vega B. Toxicol Appl Pharmacol; 2008 Jul 15; 230(2):261-8. PubMed ID: 18430447 [Abstract] [Full Text] [Related]
3. Relationship between human paraoxonase-1 activity and PON1 polymorphisms in Mexican workers exposed to organophosphate pesticides. López-Flores I, Lacasaña M, Blanco-Muñoz J, Aguilar-Garduño C, Sanchez-Villegas P, Pérez-Méndez OA, Gamboa-Avila R. Toxicol Lett; 2009 Jul 24; 188(2):84-90. PubMed ID: 19446239 [Abstract] [Full Text] [Related]
4. Association between serum paraoxonase (PON1) gene promoter T(-107)C polymorphism, PON1 activity and HDL levels in healthy Sicilian octogenarians. Campo S, Sardo MA, Trimarchi G, Bonaiuto M, Fontana L, Castaldo M, Bonaiuto A, Saitta C, Bitto A, Manduca B, Riggio S, Saitta A. Exp Gerontol; 2004 Jul 24; 39(7):1089-94. PubMed ID: 15236768 [Abstract] [Full Text] [Related]
5. Interaction of paraoxonase-192 polymorphism with low HDL-cholesterol in coronary artery disease risk. Mendonça MI, Dos Reis RP, Freitas AI, Pereira A, Sousa AC, Freitas S, Ornelas I, Freitas C, Brehm A, Araújo JJ. Rev Port Cardiol; 2010 Apr 24; 29(4):571-80. PubMed ID: 20734577 [Abstract] [Full Text] [Related]
6. Effect of physical activity on lipid levels in a population-based sample of men with and without the Arg192 variant of the human paraoxonase gene. Sentí M, Aubó C, Elosua R, Sala J, Tomás M, Marrugat J. Genet Epidemiol; 2000 Mar 24; 18(3):276-86. PubMed ID: 10723110 [Abstract] [Full Text] [Related]
7. Effect of paraoxonase 1 polymorphisms on the response of lipids and lipoprotein-associated enzymes to treatment with fluvastatin. Christidis DS, Liberopoulos EN, Kakafika AI, Miltiadous GA, Liamis GL, Kakaidi B, Tselepis AD, Cariolou MA, Elisaf MS. Arch Med Res; 2007 May 24; 38(4):403-10. PubMed ID: 17416287 [Abstract] [Full Text] [Related]
8. Genetic polymorphisms and activity of PON1 in a Mexican population. Rojas-García AE, Solís-Heredia MJ, Piña-Guzmán B, Vega L, López-Carrillo L, Quintanilla-Vega B. Toxicol Appl Pharmacol; 2005 Jun 15; 205(3):282-9. PubMed ID: 15922013 [Abstract] [Full Text] [Related]
9. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]. Gamboa R, Regalado JC, Huesca-Gómez C, Posadas-Romero C, Verdejo Paris J, Vargas-Alarcón G, Pérez-Méndez O. Arch Cardiol Mex; 2008 Jun 15; 78(4):360-8. PubMed ID: 19205543 [Abstract] [Full Text] [Related]
10. Angiotensin-I-converting enzyme (ACE) insertion/deletion polymorphism in Mexican patients with coronary artery disease. Association with the disease but not with lipid levels. Vargas-Alarcón G, Zamora J, Sánchez-García S, Rodríguez-Pérez JM, Cardoso G, Posadas-Romero C. Exp Mol Pathol; 2006 Oct 15; 81(2):131-5. PubMed ID: 16764852 [Abstract] [Full Text] [Related]
11. Antioxidant effect of atorvastatin is independent of PON1 gene T(-107)C, Q192R and L55M polymorphisms in hypercholesterolaemic patients. Sardo MA, Campo S, Bonaiuto M, Bonaiuto A, Saitta C, Trimarchi G, Castaldo M, Bitto A, Cinquegrani M, Saitta A. Curr Med Res Opin; 2005 May 15; 21(5):777-84. PubMed ID: 15969877 [Abstract] [Full Text] [Related]
16. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B, Türkanoğlu A, Bek S, Sanisoğlu Y, Demirkaya S, Vural O, Arinç E, Adali O. Clin Biochem; 2008 Jan 15; 41(1-2):1-9. PubMed ID: 17920578 [Abstract] [Full Text] [Related]
17. Distribution of paraoxonase PON1 gene polymorphisms in Mexican populations. Its role in the lipid profile. Gamboa R, Zamora J, Rodríguez-Pérez JM, Fragoso JM, Cardoso G, Posadas-Romero C, Vargas-Alarcón G. Exp Mol Pathol; 2006 Feb 15; 80(1):85-90. PubMed ID: 15993880 [Abstract] [Full Text] [Related]
19. Activity of paraoxonase 1 (PON1) and its relationship to markers of lipoprotein oxidation in healthy Slovaks. Sumegová K, Blazícek P, Waczulíková I, Zitnanová I, Duracková Z. Acta Biochim Pol; 2006 Feb 15; 53(4):783-7. PubMed ID: 17106515 [Abstract] [Full Text] [Related]
20. Association of gene polymorphisms with myocardial infarction in individuals with different lipid profiles. Yoshida T, Yajima K, Hibino T, Kato K, Matsuo H, Segawa T, Watanabe S, Oguri M, Yokoi K, Nozawa Y, Kimura G, Yamada Y. Int J Mol Med; 2007 Oct 15; 20(4):581-90. PubMed ID: 17786291 [Abstract] [Full Text] [Related] Page: [Next] [New Search]